This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1998.
Company Filing History:
1 out of 834,307 Years Active: 1998
Title: Sylvie Prigent: Innovator in Lymphoblastoid Cell Research
Introduction
Sylvie Prigent is a notable inventor based in Bures-sur-Yvette, France. She has made significant contributions to the field of biotechnology, particularly in the area of lymphoblastoid cell research. Her innovative work has led to the development of a unique plasmid vector designed for transforming lymphoblastoid cells.
Latest Patents
Sylvie Prigent holds 1 patent for her invention titled "Expression in non-tumoral human lymphoblastoid lines with an integrative - A plasmid vector designed for transforming lymphoblastoid cells, immortalized by Epstein Barr virus, for producing heterologous proteins." This patent includes bacterial DNA elements required for amplification, along with specific DNA fragments that enhance the functionality of the plasmid vector.
Career Highlights
Throughout her career, Sylvie has focused on advancing the understanding of lymphoblastoid cells and their applications in producing heterologous proteins. Her research has been instrumental in developing methods that improve the efficiency of protein production in these cells.
Collaborations
Sylvie has collaborated with esteemed colleagues such as Georges Boffa and Jean-Pierre Cartron. These partnerships have enriched her research and contributed to the success of her innovative projects.
Conclusion
Sylvie Prigent's work exemplifies the impact of innovation in biotechnology. Her contributions to lymphoblastoid cell research continue to influence the field and pave the way for future advancements.